Jan Erik Alenfall

Jan Erik Alenfall

Chief Executive Officer en Callipa AB .

62 años
Health Technology

Perfil

Jan Erik Alenfall is currently the Managing Director & Director at Callipa AB.
Previously, he worked as the Chief Executive Officer & Director at DermaGen AB, Head-Research at Probi AB, Manager-International Clinical Research at Ferring Pharmaceuticals A, Associate-Clinical Research at Pharmacia AB, Head-Clinical & Preclinical Research at Trettiosjucorp AB, Manager-International Clinical Research at Rechon Life Science AB, and Head-Clinical & Preclinical Research at SkyePharma AB.
He also served as the Chief Scientific Officer at Follicum AB from 2013 to 2021.

Cargos activos de Jan Erik Alenfall

EmpresasCargoInicio
Callipa AB Chief Executive Officer -
Todos los cargos activos de Jan Erik Alenfall

Antiguos cargos conocidos de Jan Erik Alenfall.

EmpresasCargoFin
FOLLICUM AB (PUBL) Chief Executive Officer 06/04/2021
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Jan Erik Alenfall.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jan Erik Alenfall.

Relaciones

13

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
PROBI AB

Health Technology

Empresas privadas8

Health Technology

Pharmacia AB

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Callipa AB

Health Technology

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Jan Erik Alenfall